GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Return-on-Tangible-Asset

Tauns Laboratories (TSE:197A) Return-on-Tangible-Asset : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Tauns Laboratories's annualized Net Income for the quarter that ended in Dec. 2024 was 円0 Mil. Tauns Laboratories's average total tangible assets for the quarter that ended in Dec. 2024 was 円28,863 Mil. Therefore, Tauns Laboratories's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 0.00%.

The historical rank and industry rank for Tauns Laboratories's Return-on-Tangible-Asset or its related term are showing as below:

TSE:197A' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -0.47   Med: 27.78   Max: 28.9
Current: -0.47

During the past 3 years, Tauns Laboratories's highest Return-on-Tangible-Asset was 28.90%. The lowest was -0.47%. And the median was 27.78%.

TSE:197A's Return-on-Tangible-Asset is ranked better than
51.95% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -1.23 vs TSE:197A: -0.47

Tauns Laboratories Return-on-Tangible-Asset Historical Data

The historical data trend for Tauns Laboratories's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Return-on-Tangible-Asset Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Return-on-Tangible-Asset
27.78 19.87 28.90

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
Return-on-Tangible-Asset - - - -2.03 -

Competitive Comparison of Tauns Laboratories's Return-on-Tangible-Asset

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Return-on-Tangible-Asset falls into.


;
;

Tauns Laboratories Return-on-Tangible-Asset Calculation

Tauns Laboratories's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=5774.086/( (14422.027+25540.454)/ 2 )
=5774.086/19981.2405
=28.90 %

Tauns Laboratories's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=0/( (25540.454+32184.614)/ 2 )
=0/28862.534
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2024) net income data.


Tauns Laboratories  (TSE:197A) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Tauns Laboratories Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines